Marina Biotech Demonstrates In Vivo Dose-Dependent Efficacy and High Tolerability With a CRN-Substituted miRNA Antagonist – Yahoo Finance

October 19, 2011 Posted By: Leave a comment
Additional information about Marina Biotech is available at http://www.marinabio.com. Forward-Looking Statements Statements made in this news release may be forward-looking statements within the meaning of Federal Securities laws that are subject to ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>